Reiley Pharmaceuticals Inc. Report issue

For profit Phase 1
Founded: San Jose CA United States (2014)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2018
NCT03503825
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Reiley Pharmaceuticals Inc.